GlassScriptPhysician profile
John L Buker
NPI 1457355174
$35,424.15
in general payments reported to CMS, 2019-2025
30 companies · $4,785 in 2025
The $4,785 reported for 2025 was more than what 94% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $226 · 2021: $7,650 · 2022: $8,017 · 2023: $7,467 · 2024: $6,411 · 2025: $4,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $397 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,106.40 |
| Food and Beverage | $396.55 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18,093.13 | 2019-2025 | Botox |
| Allergan, INC. | $14,591.21 | 2019-2023 | |
| Janssen Biotech, INC. | $863.04 | 2019-2024 | Tremfya |
| Pfizer INC. | $363.00 | 2019-2023 | |
| Genentech USA, INC. | $270.24 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $147.88 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $122.43 | 2019-2021 | |
| Amgen INC. | $117.25 | 2019-2022 | |
| Stemline Therapeutics INC. | $83.59 | 2021 | |
| Leo Pharma INC. | $82.30 | 2019-2022 | |
| Epi Health, LLC | $82.26 | 2019 | |
| Genzyme Corporation | $67.90 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $64.36 | 2019-2020 | |
| Celgene Corporation | $62.79 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $60.55 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $54.71 | 2019-2023 | Olumiant, Taltz |
| Sensus Healthcare, INC. | $53.66 | 2021 | |
| Incyte Corporation | $33.99 | 2021-2024 | Opzelura |
| Almirall LLC | $28.30 | 2022 | |
| Mayne Pharma Commercial LLC | $24.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.92 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.50 | 2022 | |
| Dusa Pharmaceuticals, INC. | $17.91 | 2019 | |
| Organogenesis INC. | $17.76 | 2022 | |
| Galderma Laboratories, L.P. | $17.67 | 2019 | |
| Arcutis Biotherapeutics, INC. | $17.58 | 2023 | |
| Sebela Pharmaceuticals INC. | $12.79 | 2019 | |
| Ucb, INC. | $11.97 | 2022 | |
| Encore Dermatology INC. | $11.85 | 2019 | |
| Glenmark Therapeutics INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Buker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.